Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

Dr. R.W. Mills, Chief Medical Officer for Nationwide Children's Hospital - Toledo, talks about what to know about RSV as kids ...

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

The investigators noted cardiovascular events for up to 1 year post-discharge in 18.5% of RSV patients, compared with 17.7% ...

Vaccinating pregnant women against respiratory syncytial virus (RSV) is linked to a 72% drop in newborns being hospitalized ...

Deaths due to RSV in April and May 2025 remain below the same months in 2024. The table below shows the number of acute-respiratory associated deaths where the person has died "with" the virus (a ...

We may use terms like cold and the flu as if they are the same thing, but there are some key differences between them.

A measles booster? The shingles shot? Here's expert advice on which shots you should get—and when.By Hallie LevineDiseases such as chickenpox and measles may be more than hazy memories from ...

In 2023, Taiwan’s premature birth rate was 10.88%, meaning about one in 10 newborns was born before 37 weeks of gestation.